Raymond Chuen-Chung Chang

University of Hong Kong

Dr. Chang is the Lab Chief for the Laboratory of Neurodegenerative Diseases in the School of Biomedical Sciences, member in The State Key Laboratory of Brain and Cognitive Sciences. He is also the Founder and Secretary of HKU Alzheimer’s Disease Research Network, organising International Alzheimer’s Disease Conference every year since 2000. Dr. Chang’s research interest is pathophysiological changes of Alzheimer’s disease (AD) and the risk factors leading to AD. He has published over 120 peer-reviewed papers and 14 book chapters in these areas. His h-index is 34 by Scopus, 43 by Google Scholar. He is a member in the Scientific Advisory Board of International AD/PD Symposium, Scientific Review Committee in Alzheimer Association, Senior Editor for Journal of Neuroimmune Pharmacology, and Editor-in-Chief for ‘American Journal of Alzheimer’s Disease and Other Dementias. He is the member of editorial board of more than 20 different journals, and grant reviewer for different grant agencies/Foundations.

3books edited

2chapters authored

Latest work with IntechOpen by Raymond Chuen-Chung Chang

Neuroprotection is a strategy to prevent or delay the progression of chronic neurodegenerative diseases, acute neurological disorders, or even mental disorders. The major aim of this book is to focus on different approaches to achieve neuroprotection. In this book, there are chapters discussing imidazoline ligands and opioid ligands in Alzheimer's disease, the beneficial effects of adenosine A2A receptor antagonist, adrenergic receptor agonists and antagonists modulating microglial responses, and different approaches to achieve neuroprotection against aging-associated macular degeneration. This book will give insights to scientists in the field to stimulate their research, medical professionals to review their clinical practices, and others who would like to learn more about different neuroprotective approaches.

Go to the book